Allergan Stock Buy Or Sell -

As of April 2026, . The company was acquired by AbbVie (NYSE: ABBV) in a $63 billion deal that officially closed on May 8, 2020.

Since the acquisition, AbbVie has used Allergan’s aesthetics and neuroscience portfolios to diversify its revenue. allergan stock buy or sell

: Analysts are currently focused on AbbVie's ability to offset the loss of exclusivity for its flagship drug, Humira, through newer immunology drugs like Skyrizi and Rinvoq . As of April 2026,